Extracellular Matrix Binding Properties of Recombinant Fibronectin Type II-like Modules of Human 72-kDa Gelatinase/Type IV Collagenase
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
72-kDa gelatinase/type IV collagenase is an important matrix metalloproteinase in the degradation of basement membranes and denatured collagens (gelatin). These proteolytic processes are required for pathologic tissue destruction and physiologic tissue remodeling. To investigate the molecular determinants of substrate specificity of this enzyme, a 21-kDa domain of 72-kDa gelatinase, consisting of three tandem fibronectin type II-like modules, was expressed in Escherichia coli. Similar to full-length 72-kDa gelatinase and the type II modules in fibronectin, the recombinant (r) fibronectin-like domain of this proteinase bound denatured type I collagen with an apparent Kd in the micromolar range. This domain, designated the collagen-binding domain (rCBD123), possesses at least two collagen-binding sites that can each be simultaneously occupied. rCBD123 also avidly bound elastin and denatured types IV and V collagens, but neither native types IV and V collagens nor fibronectin, all of which are substrates of the enzyme. Although 72-kDa gelatinase is involved in basement membrane degradation, rCBD123 also did not bind reconstituted basement membrane, laminin, or SPARC. Native type I collagen, which is not degraded by 72-kDa gelatinase, competed with gelatin for a shared binding site on rCBD123. rCBD123 also displaced full-length 72-kDa gelatinase bound to native type I collagen, further demonstrating that the collagen binding properties of the recombinant domain closely mimicked those of the full-length enzyme. Since rCBD123 showed reduced binding to pepsin-cleaved type I collagen, either or both of the collagen telopeptide ends contain recognition sites for the 72-kDa gelatinase fibronectin-like domain. This was confirmed by the avid binding of rCBD123 to the alpha 1(I) collagen cyanogen bromide fragment CB2 from the NH2-terminal telopeptide. rCBD123 also bound alpha 1(I)-CB7, which encompasses the fibronectin-binding site, and to alpha 1(I)-CB8, a fragment not bound by fibronectin. Thus, type I collagen contains multiple binding sites for rCBD123 which are partially masked by the triple helical conformation of native collagen and fully exposed upon unfolding of the triple helix. The potential of the fibronectin-like collagen binding domain of 72-kDa gelatinase to bind extracellular matrix proteins may facilitate enzyme localization in connective tissue matrices.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Van Wart, H. E., & Birkedal-Hansen, H. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.14.5578 · Cited by 1,475
Overall, C. M., Wrana, J. L., & Sodek, J. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)94267-5 · Cited by 636
Self-citation
Cited by
Nagase, H., & Woessner, J. F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.31.21491 · Cited by 3,912
Tjäderhane, L., Buzalaf, M. A. R., Carrilho, M., & Chaussain, C. (2015) · Caries Research · doi:10.1159/000363582 · Cited by 2,306
“Type I collagen telopeptide contains recognition sites for the gelatinase fibronectin-like domain [Steffensen et al., 1995], indicating that MMP-2 and MMP-9 telopeptidase activity may be totally separate from the gelatinolytic activity of these enzymes.”
BackgroundBiochemical and Biological Attributes of Matrix Metalloproteinases
Cui, N., Hu, M., & Khalil, R. A. (2017) · Progress in Molecular Biology and Translational Science · doi:10.1016/bs.pmbts.2017.02.005 · Cited by 1,359
Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease
Fan, D., Takawale, A., Lee, J., & Kassiri, Z. (2012) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-5-15 · Cited by 814
Inflammation Dampened by Gelatinase A Cleavage of Monocyte Chemoattractant Protein-3
McQuibban, G. A., Gong, J.-H., Tam, E. M., McCulloch, C. A. G., Clark-Lewis, I., & Overall, C. M. (2000) · Science · doi:10.1126/science.289.5482.1202 · Cited by 772
Self-citationVandooren, J., Van den Steen, P. E., & Opdenakker, G. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.770819 · Cited by 766
Gelatinase-mediated migration and invasion of cancer cells
Björklund, M., & Koivunen, E. (2005) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2005.03.001 · Cited by 661
Matrix Metalloproteinase Activity Inactivates the CXC Chemokine Stromal Cell-derived Factor-1
McQuibban, G. A., Butler, G. S., Gong, J.-H., Bendall, L., Power, C., Clark-Lewis, I., & Overall, C. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107736200 · Cited by 655
Self-citationSato, Y., Murase, K., Kato, J., Kobune, M., Sato, T., Kawano, Y., Takimoto, R., Takada, K., Miyanishi, K., Matsunaga, T., et al. (2008) · Nature Biotechnology · doi:10.1038/nbt1396 · Cited by 609
Overall, C. M. (2002) · Molecular Biotechnology · doi:10.1385/mb:22:1:051 · Cited by 504
Self-citationNakahara, H., Howard, L., Thompson, E. W., Sato, H., Seiki, M., Yeh, Y., & Chen, W.-T. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.7959 · Cited by 425
Matrix Metalloproteinase-2 Contributes to Cancer Cell Migration on Collagen
Xu, X., Wang, Y., Chen, Z., Sternlicht, M. D., Hidalgo, M., & Steffensen, B. (2005) · Cancer Research · doi:10.1158/0008-5472.130.65.1 · Cited by 413
Self-citationMatrix metalloproteinases in tumor–host cell communication
Lynch, C. C., & Matrisian, L. M. (2002) · Differentiation · doi:10.1046/j.1432-0436.2002.700909.x · Cited by 386
Regulation of matrix metalloproteinase activity in health and disease
Hadler‐Olsen, E., Fadnes, B., Sylte, I., Uhlin‐Hansen, L., & Winberg, J. (2011) · The FEBS Journal · doi:10.1111/j.1742-4658.2010.07920.x · Cited by 383
Joyce, K., Fabra, G. T., Bozkurt, Y., & Pandit, A. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00512-8 · Cited by 316
Relating matrix metalloproteinase structure to function: Why the “hemopexin” domain?
Murphy, G., & Knäuper, V. (1997) · Matrix Biology · doi:10.1016/s0945-053x(97)90025-1 · Cited by 306
The matrix metalloproteinase gelatinase A in human dentine
Martin-De Las Heras, S., Valenzuela, A., & Overall, C. M. (2000) · Archives of Oral Biology · doi:10.1016/s0003-9969(00)00052-2 · Cited by 287
Self-citationMetalloproteases and inhibitors in arthritic diseases
Martel-Pelletier, J., Welsch, D. J., & Pelletier, J.-P. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0195 · Cited by 270
Davis, V., Persidskaia, R., Baca-Regen, L., Itoh, Y., Nagase, H., Persidsky, Y., Ghorpade, A., & Baxter, B. T. (1998) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.18.10.1625 · Cited by 259
Sbardella, D., Fasciglione, G. F., Gioia, M., Ciaccio, C., Tundo, G. R., Marini, S., & Coletta, M. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2011.10.015 · Cited by 247
“CBD is made of three fibronectin II-like repeats and represents the preferential binding domain for fibrillar collagen I (Steffensen et al., 1995).”
BackgroundPatterson, M. L., Atkinson, S. J., Knäuper, V., & Murphy, G. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02723-5 · Cited by 219
Eckhard, U., Huesgen, P. F., Schilling, O., Bellac, C. L., Butler, G. S., Cox, J. H., Dufour, A., Goebeler, V., Kappelhoff, R., Keller, U. A. D., et al. (2016) · Matrix Biology · doi:10.1016/j.matbio.2015.09.003 · Cited by 212
Self-citationIntricate Functions of Matrix Metalloproteinases in Physiological and Pathological Conditions
Mittal, R., Patel, A. P., Debs, L. H., Nguyen, D., Patel, K., Grati, M., Mittal, J., Yan, D., Chapagain, P., & Liu, X. Z. (2016) · Journal of Cellular Physiology · doi:10.1002/jcp.25430 · Cited by 179
Activation of Neutrophil Collagenase in Periodontitis
Romanelli, R., Mancini, S., Laschinger, C., Overall, C. M., Sodek, J., & McCulloch, C. A. G. (1999) · Infection and Immunity · doi:10.1128/iai.67.5.2319-2326.1999 · Cited by 171
Self-citationNovel MMP-9 Substrates in Cancer Cells Revealed by a Label-free Quantitative Proteomics Approach
Xu, D., Suenaga, N., Edelmann, M. J., Fridman, R., Muschel, R. J., & Kessler, B. M. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800095-mcp200 · Cited by 162
“These early observations have since been refined as it became apparent that denatured collagen I, IV as well as gelatin are efficiently cleaved but that intact collagen I or IV are poor substrates for the enzyme (3, 4).”
BackgroundBigg, H. F., Shi, Y. E., Liu, Y. E., Steffensen, B., & Overall, C. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.24.15496 · Cited by 160
Self-citationTam, E. M., Moore, T. R., Butler, G. S., & Overall, C. M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407186200 · Cited by 142
Self-citationSiméon, A., Monier, F., Emonard, H., Gillery, P., Hornebeck, W., Maquart, F.-X., & Birembaut, P. (1999) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.1999.00606.x · Cited by 68
(2007) · Cited by 33
Karayasheva, D., Glushkova, M., Boteva, E., Mitev, V., & Kadiyska, T. (2016) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2016.03.007 · Cited by 21
Metadata
- Authors
- Steffensen, B., Wallon, U. M., & Overall, C. M.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 1995-05
- Volume
- 270
- Issue
- 19
- Pages
- 11555-11566
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2022289649
- Cited by
- 223
- References
- 2
- FWCI
- 2.54
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.